BACKGROUND: Recruitment and retention in randomized clinical trials are difficult in general and particularly so in trials of substance abuse treatments. Understanding trial design characteristics that could affect recruitment and retention rates would help in the design of future trials. OBJECTIVE: To test whether any of the following factors are associated with recruitment or retention: type of intervention, type of therapy, duration of treatment, total duration of trial, number of treatment sessions, number of follow-up visits, number of primary assessments, timing of primary assessments, number of case report form (CRF) pages at baseline, and number of CRF pages for the entire trial. METHODS: Recruitment and retention data from 24 Clinical Trials Network (CTN) trials conducted and completed between 2001 and 2010 were analyzed using single-factor analysis of variance and single-predictor regression methods to test their association with trial design characteristics. RESULTS: Almost all of the analyses performed did not show statistically significant patterns between recruitment and retention rates and the trial design characteristics considered. CONCLUSION: In CTN trials, the relationship between assessment burden on participants and length of trial, on the one hand, and recruitment and retention, on the other, is not as strong and direct as expected. Other factors must impinge on the conduct of the trial to influence trial participation. SCIENTIFIC SIGNIFICANCE: Researchers may deem slightly more justifiable to permit inclusion of some of the design features that previously were assumed to have a strong, negative influence on recruitment and retention, and should consider other strategies that may have a stronger, more direct effect on trial participation.
BACKGROUND: Recruitment and retention in randomized clinical trials are difficult in general and particularly so in trials of substance abuse treatments. Understanding trial design characteristics that could affect recruitment and retention rates would help in the design of future trials. OBJECTIVE: To test whether any of the following factors are associated with recruitment or retention: type of intervention, type of therapy, duration of treatment, total duration of trial, number of treatment sessions, number of follow-up visits, number of primary assessments, timing of primary assessments, number of case report form (CRF) pages at baseline, and number of CRF pages for the entire trial. METHODS: Recruitment and retention data from 24 Clinical Trials Network (CTN) trials conducted and completed between 2001 and 2010 were analyzed using single-factor analysis of variance and single-predictor regression methods to test their association with trial design characteristics. RESULTS: Almost all of the analyses performed did not show statistically significant patterns between recruitment and retention rates and the trial design characteristics considered. CONCLUSION: In CTN trials, the relationship between assessment burden on participants and length of trial, on the one hand, and recruitment and retention, on the other, is not as strong and direct as expected. Other factors must impinge on the conduct of the trial to influence trial participation. SCIENTIFIC SIGNIFICANCE: Researchers may deem slightly more justifiable to permit inclusion of some of the design features that previously were assumed to have a strong, negative influence on recruitment and retention, and should consider other strategies that may have a stronger, more direct effect on trial participation.
Authors: Edward V Nunes; Samuel Ball; Robert Booth; Gregory Brigham; Donald A Calsyn; Kathleen Carroll; Daniel J Feaster; Denise Hien; Robert L Hubbard; Walter Ling; Nancy M Petry; John Rotrosen; Jeffrey Selzer; Maxine Stitzer; Susan Tross; Paul Wakim; Theresa Winhusen; George Woody Journal: J Subst Abuse Treat Date: 2010-06
Authors: Jennifer Sharpe Potter; Dennis M Donovan; Roger D Weiss; John Gardin; Robert Lindblad; Paul Wakim; Dorian Dodd Journal: Am J Drug Alcohol Abuse Date: 2011-09 Impact factor: 3.829
Authors: Adam Bisaga; Efrat Aharonovich; Fatima Garawi; Frances R Levin; Eric Rubin; Wilfrid N Raby; Edward V Nunes Journal: Drug Alcohol Depend Date: 2005-10-05 Impact factor: 4.492
Authors: George E Woody; Sabrina A Poole; Geetha Subramaniam; Karen Dugosh; Michael Bogenschutz; Patrick Abbott; Ashwin Patkar; Mark Publicker; Karen McCain; Jennifer Sharpe Potter; Robert Forman; Victoria Vetter; Laura McNicholas; Jack Blaine; Kevin G Lynch; Paul Fudala Journal: JAMA Date: 2008-11-05 Impact factor: 56.272
Authors: April M Young; Kathryn E Lancaster; Sarann Bielavitz; Miriam R Elman; Ryan R Cook; Gillian Leichtling; Edward Freeman; Angela T Estadt; Morgan Brown; Rhonda Alexander; Caiti Barrie; Kandi Conn; Rhody Elzaghal; Lisa Maybrier; Renee McDowell; Cathy Neal; Jodi Lapidus; Elizabeth N Waddell; P Todd Korthuis Journal: BMJ Open Date: 2022-06-15 Impact factor: 3.006
Authors: Angela T Hetrick; April M Young; Miriam R Elman; Sarann Bielavitz; Rhonda L Alexander; Morgan Brown; Elizabeth Needham Waddell; P Todd Korthuis; Kathryn E Lancaster Journal: Trials Date: 2021-12-20 Impact factor: 2.279